Pharmabiz1d
Centre bans chloramphenicol and nitrofurans for use in food-producing animals
The Union health ministry has banned the import, manufacture, sale and distribution of antibiotic chloramphenicol and nitrofurans class of drugs for use in any food-producing animal rearing system ...
Pharmabiz1d
Centre reconstitutes DTAB
The new notification, issued on March 12 reconstitutes the 18 member committee which was constituted on October 18, 2021. The DTAB was reconstituted in May, 2018, prior to that. The revised board will ...
Pharmabiz1d
Focus on futuristic products, affordable solutions, says DoP secretary
Focus on futuristic products, affordable solutions, says DoP secretary: Our Bureau, New Delhi Thursday, March 13, 2025, 18:30 Hrs [IST] Focus on developing futuristic products and ...
Pharmabiz1d
Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes
Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:50 Hrs [IST] Corona Remedies Limited ha ...
Pharmabiz1d
Harbour BioMed launches Élancé Therapeutics to advance next-generation obesity therapies
Harbour BioMed launches Élancé Therapeutics to advance next-generation obesity therapies: Cambridge, Massachusetts Thursday, March 13, 2025, 18:00 Hrs [IST] Harbour BioMed, a gl ...
Pharmabiz1d
Wockhardt Hospitals, Mira Road successfully performs first Swap Kidney Transplant
Wockhardt Hospitals, Mira Road successfully performs first Swap Kidney Transplant: Our Bureau, Mumbai Thursday, March 13, 2025, 17:40 Hrs [IST] In a significant development that c ...
Pharmabiz1d
Mankind Pharma launches affordable empagliflozin in India for diabetes
Mankind Pharma launches affordable empagliflozin in India for diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:30 Hrs [IST] Mankind Pharma has launched its affordable gen ...
Pharmabiz1d
PolyPid completes enrollment in phase 3 SHIELD II trial of D-PLEX100 for prevention of abdominal colorectal surgical site infections
PolyPid completes enrollment in phase 3 SHIELD II trial of D-PLEX100 for prevention of abdominal colorectal surgical site infections: Petach Tikva, Israel Thursday, March 13, 2025 ...
Pharmabiz1d
QurAlis announces positive data from phase 1 trial of QRL-101 evaluating biomarkers of ALS and epilepsy in healthy volunteers
QRL-101-03 (NCT06532396) is a randomized, double-blind, placebo-controlled, multiple-ascending dose clinical trial evaluating the safety, tolerability, and PK of QRL-101 in up to 60 healthy ...
Pharmabiz1d
Lipocine announces US FDA labelling changes for testosterone products
Lipocine announces US FDA labelling changes for testosterone products: Salt Lake City Thursday, March 13, 2025, 16:00 Hrs [IST] Lipocine Inc., a biopharmaceutical company leveragi ...
Pharmabiz1d
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device: Newtown, Pennsylvania Thursday, March ...
Pharmabiz1d
Biogen begins TRANSCEND phase 3 study of felzartamab to treat late antibody-mediated rejection in kidney transplant patients
Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...